INTRODUCTION
Peroxisomes were first described in 1954 (Rhodin, 1954) , but their more important functions such as fatty acid fl-oxidation have been characterized more recently (Lazarow & de Duve, 1976) . In particular, peroxisomes probably play an important role in the oxidation of verylong-chain fatty acids (VLCFA) (greater than 22 carbon atoms in length) (Osmundsen et al., 1980; Singh et al., 1984a Singh et al., , 1987a . VLCFA are known to accumulate in several disease states (Igarashi et al., 1976; Brown et al., 1982; Moser et al., 1984; Sharp et al., 1987; Poulos et al., 1987 ) including Zellweger's syndrome, a fatal autosomal recessive disease with multiple biochemical and clinical abnormalities. The disease is characterized ultrastructurally by an absence or severe deficiency of peroxisomes (Goldfischer et al., 1973; Arias et al., 1985) . The accumulation of saturated, monounsaturated and polyunsaturated VLCFA in Zellweger tissues suggests that peroxisomes are involved in the regulation of catabolism or biosynthesis of these fatty acids.
A number of studies have described the elongation and desaturation of long-chain (greater than 14 carbon atoms in length) and very-long-chain saturated and polyunsaturated fatty acids by human tissues. Rosenthal & Hill, working with cultured human endothelial cells, reported that a number of VLCFA, including C24 4, C24:5 C26 4 and C26 were synthesized from C20 3,n (Rosenthal & Hill, 1984) and subsequently demonstrated elongation of C20:5,n,3 to C22:5 and C20.4 6 to C22:4 (Rosenthal & Hill, 1986) . Human skin fibroblasts in culture have been shown to elongate C22: 4,n (Gavino et al., 1981) , C20:3, C20:4 and C20:5 (Banerjee & Rosenthal, 1986 ) and the saturated fatty acids Ci6,0, C18:0, C20:0 and C22: 0 (Tsuji et al., 1984) . Recently, Christensen et al. (1988) have reported that normal and Zellweger's syndrome fibroblasts can elongate C22:1,n-9 to C24:1,n-9 and C18:3,n-3 to a number of elongated products including C20 and C22 polyunsaturated fatty acids.
Metabolic products from long chain fatty acid (LCFA) and VLCFA oxidation in normal and peroxisomaldeficient skin fibroblasts have not been fully characterized. Traditionally, oxidation of fatty acids has been determined by measurement of 14CO2 production from 14C-labelled fatty acids, although several studies have reported, in addition, formation of water-soluble products in various tissue preparations (Van Hinsbergh et al., 1978; Rosenthal & Hill, 1984 ; Kondrup & Lazarow, 1985; Christensen et al., 1986) . identified the water-soluble product from lignocerate and stearate in disrupted fibrobla-st cell homogenates as predominantly acetyl-CoA. In rat brain preparations glutamate was the principal water-soluble product from lignoceric (Uda et al., 1981) and palmitic acids (Kawamura & Kishimoto, 1981) . Tissue differences are apparent since palmitic acid oxidation by rat liver preparations gave rise to mainly organic acids, with amino acids as a minor component (Kawamura & Kishimoto, 1981 ,f-oxidation and metabolic products from fatty acids. In the present paper we report the metabolism of the LCFA palmitic (C16: 0) and arachidonic (C20 4n) acids as well as the VLCFA lignoceric (C24: 0, n-) and tetracosatetraenoic (C24: 4,n) acids in cultured human skin fibroblasts from normal subjects and patients with Zellweger's syndrome.
MATERIALS AND METHODS

Materials
All solvents used were from May and Baker Australia Pty. Ltd., VIC or from Ajax Chemicals, Sydney, NSW, Australia. Reversed-phase KC-18 t.l.c. plates were purchased from Whatman Inc., Clifton, NJ, U.S.A. and thin-layer silica gel 60 plates were from E. . [1-14C]Tetracosatetraenoic acid (C24: 4 n-6) was prepared in the following manner. 10, 13, Cultured skin fibroblasts from normal subjects and Zellweger patients were grown in tissue culture flasks (25 cm2) in BMEM containing 10 0 (v/v) fetal calf serum for 7-10 days until confluent. The culture medium was removed and the cells were incubated in BMEM without fetal calf serum for 24 h prior to addition of substrate. Between 3 and 5 different normal and Zellweger cell lines were used with each substrate. Preparation of substrates Radiolabelled arachidonic and tetracosatetraenoic acids (15-30 nmol) were dried under N2 and incubated in 0.6 M-NaOH (5 ,dl) and fetal calf serum for 30 min at 37 'C. BMEM was added and the substrate was sterilized by passage through a Millex-GS filter (0.22 ,tm pore size). The final concentration of fetal calf serum was 1-2 0. The substrate mixture was gassed with CO2 prior to addition to the fibroblast cultures. Under these conditions, 70%0 of the substrate bound to fetal calf serum and passed through the filter.
Radiolabelled lignoceric and palmitic acids, which are not efficiently bound to fetal calf serum, were bound to bovine serum albumin (fatty-acid free) as follows. The substrates were incubated in 0.6 M-NaOH (5 ,ll) and ethanol (300 ,1) at 75 'C for 15min. After cooling to room temperature, 1 ml of fatty-acid free bovine serum albumin (50 mg/ml) was added slowly and the substrates incubated at 370 C for 60 min. Fetal calf serum and BMEM were added, and the substrates were sterilized and further prepared as described above. Incubation of 1-14C-labelled fatty acids with fibroblasts in culture Prepared substrates (approx. 4 nmol; 5 x 105 d.p.m.) were added to confluent normal and Zellweger cell cultures, and the flasks were sealed with sterilized rubber stoppers. Corresponding control incubations were done in culture flasks without cells. After incubation at 37°C for periods between 7 h and 4 days, the released "4CO2 was quantified as described previously (Poulos, 1981) .
The medium was removed and the cells washed with Dulbecco's phosphate-buffered saline (Ca2+-and Mg2+-free) prior to harvesting in 3 ml of 0.1 00 (v/v) Triton X-100. The harvested cells were disrupted by ultrasonication and an aliquot (100 ,ul) was assayed for protein as described by Bradford (1976) . All substrates and cell lines were incubated under similar conditions with similar amounts of added radioactivity.
Lipid extraction and analysis
Lipids were extracted from the media and cell suspension by the Bligh & Dyer (1959) method. BHT was added at all stages of extraction and analysis, to minimize auto-oxidation of unsaturated fatty acids. Lipid hydrolysis and methylation of the liberated fatty acids in the lower phase were carried out in methanol/H2SO4 (200:3, v/v) at 75 'C for 3 h. The methyl esters were extracted with 3 ml of hexane and purified by t.l.c. on a silica gel 60 t.l.c. plate in dichloromethane. The zone corresponding to the fatty acid methyl esters was revealed under u.v. light after spraying with dichlorofluorescein (DCF) (0.1 Qo, w/v) in methanol/water (95:5, v/v). The scraped regions of gel were extracted with 3 ml of chloroform/methanol (2: 1, v/v). The DCF was removed by partitioning with 1 drop of 2 M-NH40H and 600,ul of 0.1 M-KCl. The bottom layer was washed with 500 ,1 of synthetic upper phase (Folch et al., 1957) . Extracted fatty-acid methyl esters were applied to reversedphase KC-18 plates and developed twice in the same direction in acetonitrile/tetrahydrofuran (90:10, v/v). Appropriate standards were co-chromatographed to assist identification of the products. Autoradiographs were prepared by exposing 3H-labelled Ultrafilm to the plates for 5-10 days. Argentation t.l.c.
Argentation t.l.c. was used to separate fatty acid groups on the basis of the degree of unsaturation. Silica-gel 60 plates (20 cm x 20 cm, 0.25 mm) were sprayed with AgNO3 as described previously (Inomata et al., 1982) and fatty-acid methyl esters were chromatographed in hexane/ether (95:5, v/v). Mixtures of C16 24 saturated, mono-unsaturated and polyunsaturated fatty acids were co-chromatographed to assist identification of the products. After spraying the plate with DCF, bands were revealed under u.v. light and extracted as described above. The saturated, mono-unsaturated and polyunsaturated fatty acids groups were further separated by reversed-phase t.l.c. as described above. Hydrogenation
Cell lipid extracts were hydrogenated in order to gain information about fatty-acid chain length. The extracts were diluted to 5 ml with hexane, and palladium catalyst (0.1 g) was added. The solution was stirred vigorously under hydrogen for 7 h, filtered and the product chromatographed by reversed-phase t.l.c. as described above.
Identification of water-soluble product
Preliminary experiments characterizing the radiolabelled product observed in the aqueous phase, following partitioning of media and cell extracts, showed that the product was not volatile (> 90 %) and that no volatile product was released by alkaline hydrolysis. Only small amounts of the compound(s) were extracted from acidified aqueous solution with ethyl acetate or diethyl ether (< 10 %) and extractable products were not released by alkaline hydrolysis or methanol/H2SO4 trans-esterification. The compound(s) were removed by dialysis against water using dialysate tubing with a molecular mass cutoff of 20 000 Da. Although partially soluble in chloroform and soluble in chloroform/methanol (2:1, v/v), the product(s) were preferentially extracted from the latter into aqueous solution (> 75 %). Using the Bligh & Dyer (1959) extraction method, some losses of these products may occur on partitioning because of incomplete extraction.
The upper aqueous phase extract resulting from the extraction of conditioned medium (5 ml of medium) was dried under N2. The radiolabelled product was dissolved in 2 x 10 ml of aqueous solution adjusted to pH 2 with 0.1 M-HCl and applied to a Dowex 50 column (7 cm x 1 cm) prepared in water. The column was washed with 40 ml of water and eluted with 20 ml of 2 Mammonia. In four experiments using radiolabelled product from C20 and C24:4 441-48 0 of the radioactive product was not retained by the column and 45-640% was retained until eluted with ammonia. No radioactivity was observed in the aqueous wash. The non-retained and retained fractions were reapplied to new Dowex 50 columns under similar conditions and exhibited consistent elution patterns with that observed with initial separation. On the basis of these results the retained fractions were assayed for the presence of radiolabelled amino acids by t.l.c. and by ion-exchange chromatography. T.l.c. was carried out on cellulose plates in acetone/n-butanol/acetic acid/water (35:35:10:20, by vol.) Before ion-exchange chromatography, pooled samples were treated with an equivalent volume of sulphosalicylic acid solution (20 %, w/v), centrifuged (1000 g, 10 min) and the supernatant so formed diluted 1:1 with 0.24 M-lithium citrate buffer, pH 2.75, containing 100 /amol of norleucine/l as the internal standard.
The amino acids were separated on a cation-exchange column using lithium citrate buffers and a Dionex Amino Acid Analyser. Detection was carried out by post-column derivatization using o-phthalaldehyde in borate buffer, pH 10.4. Retention times of individual amino acids were determined using Pierce amino acid standard mixtures.
The non-retained fraction was analysed for volatility and solubility characteristics. As with the total watersoluble product, the product was not volatile (< 20 %) and no volatile product was released on alkaline hydrolysis. Following alkaline hydrolysis the compounds could not be extracted into hexane and only a small proportion (10 %o), also non-volatile, was extracted by ethyl acetate.
RESULTS
Uptake and incorporation into lipids
In 3 days, 37-660 of the radioactivity from [1-14C]-arachidonic acid added to normal cell cultures was recovered in the lipid extracts of the cells. In contrast, [90] [91] [92] [93] [94] [95] on the type of fatty acid substrate, uptake efficiency and incubation period (Fig. 1) (Fig. 1) .
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Formation of water-soluble product Monitoring of labelled products, subsequent to partitioning of media and cell extracts from control cell cultures, showed that considerable radioactivity appeared in the upper aqueous phase, particularly in media extracts from polyunsaturated fatty acids. Watersoluble radiolabelled compounds comprised as much as 34°0 of the added radioactivity in normal fibroblast cultures incubated with [1_14C]C24:4, with 9500 of the water-soluble product in the media extract and only 50 in the cell extract. Zellweger fibroblast cultures exhibited a markedly reduced capacity to produce the watersoluble product from the longer-chain radiolabelled fatty acid substrates C20:4, C24:0, and C24:4. In contrast, synthesis of the water-soluble product from [1-14C]-palmitic acid (C16:0) was similar (5-8 00 of added labelled substrate) in both normal and peroxisomedeficient cell lines.
As with 14CO2 synthesis, the amount of water-soluble product observed in normal cell cultures was dependent upon the fatty acid substrate, uptake efficiency and incubation period (Fig. 2) . Synthesis of radiolabelled water-soluble product was greater than 14CO2 production with all cell lines and all substrates. Characterization of the water-soluble product Preliminary experiments on volatility and solubility showed that acetate and acetyl-CoA were not major radiolabelled metabolic products from the long-chain fatty acids in normal fibroblast cultures. However, 45-640% of the water-soluble product(s) was retained by a strong cation-exchange column.
Amino acid analysis of this fraction suggests that these products are a series of amino acids including glutamine, asparagine and glutamic acid. The identity of the other one or two amino acid products has not as yet been established, although on a cation-exchange column radioactivity co-eluted with aspartic acid and glycine. The identity of the product(s) not retained on cation-exchange columns is not known.
DISCUSSION
The marked difference between normal and Zellweger skin fibroblasts in production of CO2 and water-soluble compounds from C20:4, C24:0 and C24:4 fatty acids suggests that in skin fibroblasts these substrates are predominantly oxidized in peroxisomes with mitochondrial oxidation contributing only a minor role. This is in agreement with previous work using the saturated VLCFA C24:0, in our laboratory Poulos et al., 1986; Singh et al., 1987a,b) and others (Osmundsen et al., 1980; Singh et al., 1984a,b) . In contrast, palmitic acid, as shown in this study and others (Lazarow & de Duve, 1976; Singh et al., 1984a; Kondrup & Lazarow, 1985) can be effectively degraded by f-oxidation in mitochondria. Our findings do not preclude some contribution of peroxisomal oxidation in the degradation of palmitic acid in the intact cell (Lazarow & de Duve, 1976; Kondrup & Lazarow, 1985) . Although it has been demonstrated that hepatic peroxisomes can fioxidize long-chain polyunsaturated fatty acids (Hiltunen et al., 1986; Havik & Osmundsen, 1987) , several studies have suggested that mitochondrial fl-oxidation is the main route for C20:4 degradation (Osmundsen & Bjornstad, 1985; Christensen et al., 1986; Hiltunen et al., 1986) . In our present work, degradation of both the polyunsaturated fatty acids C20 :4 and C24 :4 to 14CO2 and 14C-labelled water-soluble products is markedly decreased in Zellweger fibroblasts compared with controls. These results suggest that peroxisomal function is necessary, at least in the initiation of oxidation of arachidonic acid, as well as for longer chain polyunsaturated fatty acids, in cultured skin fibroblasts. This discrepancy with previously described work may be due to tissue or species differences. However, the use by Christensen et al. (1986) of decanoylcarnitine to inhibit mitochondrial f-oxidation and hence show the relative roles of peroxisomal and mitochondrial f-oxidation pathways, is controversial, with the recent evidence that the carnitine acyltransferase found on the outer surface of mitochondria may be due to peroxisomal contamination of mitochondrial preparations (Vamecq, 1987; Healy et al., 1988; Ramsay, 1988) . The role of peroxisomal carnitine acyltransferase is not well defined, but it may be important in the transport of short-chain acylCoAs from the peroxisomes and hence determine their availability for further mitochondrial metabolism, or it may regulate fatty acid entry into the peroxisome (Vamecq, 1987) . More recently, in accordance with our findings, f-oxidation of C22 unsaturated fatty acids was shown to be impaired in cultured Zellweger skin fibroblasts in comparison with controls (Christensen et al., 1988) . These results support our contention that chain shortening of fatty acids longer than C18 is principally a peroxisomal function. With all the substrates used in this study, production of labelled water-soluble material from degradation of the fatty acids was greater than 14C02 production, in control (x 7.6 + 5.4) and Zellweger (x 4.4 + 2.4) fibroblasts. The distribution between CO2 and watersoluble products is similar to that described previously for 1-_14C-labelled fatty acids (Kondrup & Lazarow, 1985; Christensen et al., 1986) . In our studies the ratio of 14C-labelled water-soluble product/14C02 decreased with time of incubation in all cases, suggesting that the watersoluble products were produced prior to CO2 production. It (McGarry et al., 1977; Kawamura & Kishimoto, 1981; Glatz et al., 1983) , rat skeletal muscle mitochondria (van Hinsberg et al., 1978) , rat brain homogenates (Uda et al., 1981) , isolated rat hepatocytes (Kondrup & Lazarow, 1985) , fibroblast homogenates , rat tissue homogenates (Veerkamp et al., 1986) and human muscle preparations (Veerkamp et al., 1986) , few studies have attempted to identify them. Our preliminary experiments suggest that in fibroblast cultures, acetate and short-chain fatty acids or their CoA derivates, when produced, are converted to other products. However, from their behaviour on t.l.c. and ion-exchange column chromatography, there is evidence to suggest that a significant proportion of the product comprises a series of amino acids including glutamate, glutamine and asparagine. These amino acids are presumbaly produced by incorporation of labelled acetyl-CoA into the tricarboxylic acid cycle followed by transamination of labelled tricarboxylic acid cycle intermediates.
Although the amino acids formed in our studies from fl-oxidation of fatty acids may represent a net production important in these and other functions within the fibroblast cell, their appearance may also represent simple dilution of label by exchange with the unlabelled amino acids in the culture medium. The high activity of the transaminase systems involved and the rapid exchange of glutamate across mitochondrial and plasma membranes would support this contention. Other studies using disrupted fibroblast cell homogenates and rat skeletal muscle mitochondria (van Hinsbergh et al., 1978) identified the water-soluble products as acetyl-CoA and citric acid cycle intermediates respectively. The short incubation periods involved, disrupted systems and absence of excess unlabelled amino acids may well prevent significant transfer of label to amino acids in these systems. However, rat brain preparations with added amino acids in the assay medium and incubations of 6-10 min were shown to oxidize [1-'4C]-palmitic acid to amino acids (mainly glutamate and aspartate) and organic acids (mainly citrate) (Kawamura & Kishimoto, 1981) . Similar experiments with rat liver preparations showed that in this tissue the principal water-soluble products were succinate, citrate and 3-hydroxybutyrate with minor amounts of amino acids (Kawamura & Kishimoto, 1981) . Glutamate has been also identified as a major product of lignoceric fatty acid oxidation in rat brain preparations (Uda et al., 1981) . These preparations were incubated in the presence of considerable crude material from calf cerebellum and the amino acid composition of the incubation system is unknown. The small amounts of labelled saturated and monounsaturated fatty acids observed in control fibroblast cultures presumably reflect ,-oxidation and recycling of labelled acetate moieties in synthesis de novo or chain elongation of endogenous fatty acid. This contention is supported by the complete absence of saturated and mono-unsaturated fatty acids in media and cell extracts from Zellweger syndrome fibroblast cultures in which peroxisomal f-oxidation is absent or severely reduced. The longer-chain-length fatty acids (> C18) and proportionately greater conversion to these products seen with polyunsaturated fatty acids is presumably due to increased amounts of available labelled acetate with these substrates. Synthesis of long-chain fatty acids Vol. 260 de novo has been described by other workers in fibroblast cell cultures (Tsuji et al., 1984) , rat brain preparations (Uda et al., 1981) and endothelial cell cultures (Rosenthal & Hill, 1984) . Recycling of labelled acetate in normal cell lines into shorter-chain fatty acids may also account for differences in mono-unsaturated and polyunsaturated fatty acid patterns observed between control and Zellweger cells lines incubated with C24 :4 C24:4, C24:0 and also C20:4 were all presumably elongated by addition of C2 units by the action of microsomal or mitochondrial elongases. The longest chain lengths seen with normal fibroblast cultures were their corresponding C26 polyunsaturated or saturated fatty acids. The apparent termination of elongation at this point is possibly due to the low amounts of available substrate, because C28 elongation products were observed in Zellweger's syndrome, albeit in trace amounts; moreover, increased conversion to all elongation products occurred in Zellweger syndrome cell extracts. As the catabolism of VLCFA is severely impaired in Zellweger fibroblast cells, added labelled substrates are channelled principally into elongated and desaturated metabolites. Conversion of VLCFA substrates to more polar metabolites such as prostaglandins and leukotrienes (Samuelsson, 1983) was not assessed.
The use of Zellweger syndrome cell lines, in which peroxisomes are absent, permits assessment of the peroxisomal role in the metabolism of fatty acids. Our results show that peroxisomal function is essential for the effective catabolism of the VLCFA C24 :0 and C24:4, as well as for C20:4, and that prevention of their normal catabolism in peroxisomes channels these fatty acids into elongated metabolites. This provides a possible mechanism for regulation of availability of the VLCFA for elongated and oxygenated metabolites. The role of the VLCFA in normal tissues is not clear, but their accumulation in peroxisomal disorders Sharp et al., 1987) may contribute to the neurodegeneration and other clinical symptoms characteristic of some of these diseases. Analysis of the products of fatty acid catabolism in normal fibroblasts suggests that an important role of peroxisomes is provision of acetylCoA for synthetic functions, such as synthesis of saturated and monounsaturated fatty acids de novo. The role of conversion of label into other water-soluble products is less certain, but our work supports previous studies in showing that analysis of 14C02 alone is not a sufficient index of ,-oxidation of fatty acids.
